These innovative therapies , Tirzepatide , represent a remarkable advancement in managing metabolic dysfunction and possibly related ailments . They all are classified as GLP-1 receptor agonists , https://alyssagqug996260.blogdosaga.com/41545821/semaglutide-a-thorough-dive-into-metabolic-compounds